Patent classifications
C12Q2521/525
QUANTITATIVE DETERMINATION OF NUCLEOSIDE ANALOGUE DRUGS IN GENOMIC DNA OR RNA
This application provides methods to quantitate drug incorporation into DNA and of simultaneously measuring DNA methylation levels. Drugs include nucleoside analog DNA methyltransferase inhibitors.
QUANTITATIVE DETERMINATION OF NUCLEOSIDE ANALOGUE DRUGS IN GENOMIC DNA OR RNA
This application provides methods to quantitate drug incorporation into DNA and of simultaneously measuring DNA methylation levels. Drugs include nucleoside analog DNA methyltransferase inhibitors.
Vesicular linker and uses thereof in nucleic acid library construction and sequencing
Provided are a vesicular linker and a single-chain cyclic library constructed by using the linker. The library can be used for RNA sequencing and other sequencing platforms dependent on a single-stranded cyclic library, and has the advantages of high throughput sequencing, high accuracy and simple operations.
Vesicular linker and uses thereof in nucleic acid library construction and sequencing
Provided are a vesicular linker and a single-chain cyclic library constructed by using the linker. The library can be used for RNA sequencing and other sequencing platforms dependent on a single-stranded cyclic library, and has the advantages of high throughput sequencing, high accuracy and simple operations.
USE OF SIMULTANEOUS MARKER DETECTION FOR ASSESSING DIFUSE GLIOMA AND RESPONSIVENESS TO TREATMENT
The present disclosure relates to a method to detect simultaneously mutations and methylation levels in a biological sample of a subject. In particular the present disclosure is directed to a method for diagnosing a central nervous system tumor such as a diffuse glioma, in a subject and comprises the steps ofdetermining at the same time the presence or absence of a mutation and methylation levels in one or more regions of interest.
USE OF SIMULTANEOUS MARKER DETECTION FOR ASSESSING DIFUSE GLIOMA AND RESPONSIVENESS TO TREATMENT
The present disclosure relates to a method to detect simultaneously mutations and methylation levels in a biological sample of a subject. In particular the present disclosure is directed to a method for diagnosing a central nervous system tumor such as a diffuse glioma, in a subject and comprises the steps ofdetermining at the same time the presence or absence of a mutation and methylation levels in one or more regions of interest.
Pyrophosphorolytic sequencing
A method for determining the sequence of a target nucleic acid, including steps of contacting a target nucleic acid with a polymerase to sequentially remove nucleotide triphosphates from the target nucleic acid, wherein the nucleotide triphosphates that are removed have a variety of different base moieties; and distinguishing the different base moieties for the nucleotide triphosphates that are removed. Also provided is a apparatus including a nanopore positioned in a fluid impermeable barrier to form a passage through which a nucleotide triphosphate can pass from a first fluid reservoir to a second fluid reservoir, and a reaction mix in the first fluid reservoir that includes a polymerase, target nucleic acid having two strands, and pyrophosphorolytic concentration of pyrophosphate.
Pyrophosphorolytic sequencing
A method for determining the sequence of a target nucleic acid, including steps of contacting a target nucleic acid with a polymerase to sequentially remove nucleotide triphosphates from the target nucleic acid, wherein the nucleotide triphosphates that are removed have a variety of different base moieties; and distinguishing the different base moieties for the nucleotide triphosphates that are removed. Also provided is a apparatus including a nanopore positioned in a fluid impermeable barrier to form a passage through which a nucleotide triphosphate can pass from a first fluid reservoir to a second fluid reservoir, and a reaction mix in the first fluid reservoir that includes a polymerase, target nucleic acid having two strands, and pyrophosphorolytic concentration of pyrophosphate.
METHOD OF PREPARATION OF NANOPORE AND USES THEREOF
This disclosure provides systems and methods for sequencing nucleic acids using nucleotide analogues and translocation of tags from incorporated nucleotide analogues through a nanopore. In aspects, this disclosure is related to composition, method, and system for sequencing a nucleic acid using tag molecules and detection of translocation through a nanopore of tags released from incorporation of the molecule.
METHOD OF PREPARATION OF NANOPORE AND USES THEREOF
This disclosure provides systems and methods for sequencing nucleic acids using nucleotide analogues and translocation of tags from incorporated nucleotide analogues through a nanopore. In aspects, this disclosure is related to composition, method, and system for sequencing a nucleic acid using tag molecules and detection of translocation through a nanopore of tags released from incorporation of the molecule.